Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Jan 04, 2021 9:49pm
167 Views
Post# 32221357

QSC $ 5 million PP INCREASES PROFIT MARGINS to 65%.....

QSC $ 5 million PP INCREASES PROFIT MARGINS to 65%.....The PP of $ 5 million will pay down some debt therefore, QSC saves interest payments.

In addition QSC now has funds to quickly expand cubes without having to wait for insurance funds that take 60 days to 90 days.  

QSC also saves cost of financing receivables preferring to keep sale funds in its pockets.

In latest press release QSC said it was opening a cube and was paid the rent with 350 antigen tests per month given to the municipality.    This saved QSC money.

A common theme arises:         KEEP PROFIT MARGINS OF 55% AND INCREASE THEM.

If QSC has done factoring, then margins go down.   If QSC keeps debts on books, then interest eats into their dollars and, any money made cannot be used for growth but must be used to pay debts.

QSC prefers to GROW.

Canaccord could solve this delema for them but they wanted a deal.  Cost would be some dilution and shares at 25 cents.   In return QSC maintains HIGH PROFIT MARGINS and gets Cannacord to bring investors to QSC.

After reflection and putting emotions aside, THIS WAS A VERY SMART DECISION. 

We can now realistically expect 125 cubes by January 31st.

MPO
<< Previous
Bullboard Posts
Next >>